Suitable biomarkers for post-mortem differentiation of cardiac death causes: Quantitative analysis of miR-1, miR-133a and miR-26a in heart tissue and whole blood

Forensic Sci Int Genet. 2023 Jul:65:102867. doi: 10.1016/j.fsigen.2023.102867. Epub 2023 Mar 31.

Abstract

Cardiovascular diseases are the most common causes of death worldwide. Cardiac death can occur as reaction to myocardial infarction (MI). A diagnostic challenge arises for sudden unexpected death (SUD) cases with structural abnormalities (SA) or without any structural abnormalities (without SA). Therefore, the identification of reliable biomarkers to differentiate cardiac cases from each other is necessary. In the current study, the potential of different microRNAs (miRNAs) as biomarkers in tissue and blood samples of cardiac death cases was analyzed. Blood and tissue samples of 24 MI, 21 SUD and 5 control (C) cases were collected during autopsy. Testing for significance and receiver operating characteristic analysis (ROC) were performed. The results show that miR-1, miR-133a and miR-26a possess a high diagnostic power to discriminate between different cardiac death causes in whole blood and in tissue.

Keywords: Biomarkers; FFPE tissue; MicroRNAs; Myocardial infarction; Quantitative analysis; Sudden cardiac death; Sudden infant death; Sudden unexpected death; Whole blood.

MeSH terms

  • Autopsy
  • Biomarkers
  • Death, Sudden, Cardiac*
  • Humans
  • MicroRNAs* / genetics
  • Myocardial Infarction* / diagnosis
  • Myocardial Infarction* / genetics

Substances

  • Biomarkers
  • MicroRNAs
  • MIRN1 microRNA, human